Buy ELIQUIS (apixaban) Online Without Prescription

Buy ELIQUIS (Apixaban): Understanding its Role in Preventing Blood Clots 
 
If you are looking to buy Medications online without prescription in Canada, https://www.oncallpharmacy.ca is a convenient and reliable option. This online platform allows you to order your medications from the comfort of your home, saving you time and simplifying the process. With an intuitive interface and secure payment options, https://www.oncallpharmacy.ca ensures a seamless experience for those who want to access Medications without the need for a doctor's prescription.
 
Buy ELIQUIS is a prescription medication used to prevent blood clots in people with certain medical conditions. It belongs to a class of drugs known as factor Xa inhibitors, which work by blocking a key clotting factor in the blood. This comprehensive guide provides detailed information about ELIQUIS, including its mechanism of action, indications, dosage instructions, potential side effects, and important safety considerations.
 
What is ELIQUIS (Apixaban)?
 
ELIQUIS is an anticoagulant medication that helps prevent blood clots from forming. It contains apixaban, a factor Xa inhibitor that blocks a specific step in the blood clotting process. By inhibiting factor Xa, ELIQUIS reduces the risk of blood clots forming in the veins and arteries.
 
How Does ELIQUIS Work?
 
Blood clotting is a complex process that involves several steps and factors. One crucial step is the activation of factor X, which leads to the formation of thrombin, a key enzyme in clot formation. ELIQUIS directly inhibits factor Xa, interrupting this process and preventing clot formation.
 
What is ELIQUIS Used For?
 
ELIQUIS is approved for several indications, including:
 
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF): NVAF is a common heart rhythm disorder that increases the risk of stroke. ELIQUIS helps prevent blood clots from forming in the heart and traveling to the brain, reducing stroke risk.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE): DVT is a blood clot that forms in a deep vein, usually in the legs. PE occurs when a DVT breaks loose and travels to the lungs. ELIQUIS helps treat these conditions by preventing existing clots from growing and new clots from forming.
Prevention of DVT and PE in patients who have undergone hip or knee replacement surgery: Surgery increases the risk of blood clots. ELIQUIS helps prevent these clots from forming after surgery.
 
Dosage Information:
 
The dosage of ELIQUIS varies depending on the indication and individual patient factors. Your healthcare provider will determine the appropriate dose for you.
 
Here's a general overview of common dosages:
 
Nonvalvular Atrial Fibrillation (NVAF): The usual dose is 5 mg twice daily. However, a 2.5 mg twice daily dose may be appropriate for certain patients, such as those with two or more of the following characteristics: age 80 years or older, body weight 60 kg or less, or serum creatinine of 1.5 mg/dL or greater.
Treatment of DVT and PE: The usual dose is 10 mg twice daily for the first 7 days, followed by 5 mg twice daily.
Prevention of DVT and PE after hip or knee replacement surgery: The usual dose is 2.5 mg twice daily, starting 12 to 24 hours after surgery.
 
It is crucial to follow your healthcare provider's instructions regarding dosage and not adjust the dose or stop taking ELIQUIS without consulting your doctor.
 
Potential Side Effects of ELIQUIS:
 
Like all medications, ELIQUIS can cause side effects. Common side effects include:
 
Bleeding: ELIQUIS increases the risk of bleeding, including nosebleeds, easy bruising, and bleeding gums.
Anemia: A decrease in red blood cells can occur.
Nausea: Stomach upset may occur.
Rash: Skin rash or itching may occur.
 
Serious Side Effects:
 
While rare, serious side effects can occur. These include:
 
Major bleeding: Bleeding in the brain, stomach, or intestines can be life-threatening.
Spinal or epidural hematoma: Bleeding around the spinal cord can occur in patients receiving spinal anesthesia or epidural injections while taking ELIQUIS.
 
Important Safety Information:
 
Active bleeding: ELIQUIS should not be used in patients with active bleeding.
Increased bleeding risk: Use with caution in patients with conditions that increase the risk of bleeding, such as recent surgery, history of bleeding problems, or use of other medications that affect blood clotting.
Liver problems: ELIQUIS should be used with caution in patients with severe liver disease.
Pregnancy and breastfeeding: The safety of ELIQUIS during pregnancy and breastfeeding has not been established. Consult your doctor before using ELIQUIS if you are pregnant, planning to become pregnant, or breastfeeding.
Drug interactions: ELIQUIS can interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Inform your doctor about all other medications you are taking.
 
Conclusion:
 
Buy ELIQUIS is an effective medication for preventing and treating blood clots in various medical conditions. It is important to understand the potential benefits and risks of ELIQUIS and to follow your healthcare provider's instructions carefully.